|
|
|||||||||||||||||||||||||||
|
BG Medicine Inc (BGMD) BG Medicine is a commercial stage company that is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders. Co. has two diagnostic tests, the first of which is the BGM Galectin-3® Test for measuring galectin-3 levels in blood plasma for use as an aid in assessing the prognosis of patients diagnosed with heart failure, available as a blood test in the U.S. and the European Union. The second diagnostic test is the CardioSCORE™ Test, a multi-analyte biomarker-based blood test that is designed as an aid in the assessment of near-term risk for atherothrombotic cardiovascular events, such as heart attack and stroke.
|
|
|||||||||||||||||||||||||||
Free BGMD Email Alerts:
BG Medicine Inc (BGMD) Page | The Online Investor | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.